Refractory Autoimmune Diseases
1 clinical trials · Condition
◉ Watch Refractory Autoimmune Diseases
| Record | Firm | Date |
|---|---|---|
| A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases (NCT07115745) | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2025-09-04 |
Track Refractory Autoimmune Diseases automatically
Every clearance here is in the API, with alerts when new ones post.